ArticleEClinicalMedicine2024

Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial.

Jonathan W Friedberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.